TAG:
american pathology
AmeriPath Will Acquire Inform DX for $44.6 Mil
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: It’s another example of consolidation in the anatomic pathology marketplace. AmeriPath, Inc.’s acquisition of Inform DX, Inc. positions the company to do as much as $350 million in revenues next year. By acquiring Inform DX, AmeriPath also gains entry into six more states…
Humana Denies Payment For Pathology CPT Codes
By Robert Michel | From the Volume VII No. 6 – April 17, 2000 Issue
CEO SUMMARY: It’s not just the Medicare program that wants to eat away at the reimbursement for laboratory tests. Private payers continue to seek ways to cut back reimbursement to laboratory providers. The latest attack is on two surgical pathology codes—88300 and 88302. In at least t…
New Blood Entering the Lab Industry
By R. Lewis Dark | From the Volume VII No. 2 – January 24, 2000 Issue
SURPRISE! THERE’S A QUIET MANAGEMENT REVOLUTION UNDER WAY in both the clinical laboratory industry and pathology profession. During the past few years, a steady flow of new-thinking Presidents and CEOs have taken control of laboratories, pathology group practices, and vendor companies. From CEO Ke…
UroCor, Unilab, AmeriPath, MedPartners, Epitope
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
UROCOR INKS PACT TO MATCH DIAGNOSTICS WITH THERAPEUTICS HERE’S A PIONEERING EFFORT to more closely link diagnostics and therapeutics into a single product package. UroCor, Inc. and Mallinckrodt, Inc. signed an agreement that allows Mallinckrodt to sell an…
American Path Resources Bought By Pathology PPM
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: Here is first confirmation that Pathology Consultants of America has indeed purchased American Pathology Resources. The combination of the two pathology-based physician practice management companies demonstrates that the pathology industry is on the verge of rapid transformat…
Pathology PPM Appears Ready To Hit Marketplace
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: After several months of delays, Physician Solutions recruited a new CEO and completed arrangements to receive $20 million in venture capital funding. These two milestones mean that the pathology-based physician practice management company will soon be ready to launch formal b…
Selling A Path Practice Requires Knowledge, Savvy & Good Timing
By Robert Michel | From the Volume V No. 4 – March 23, 1998 Issue
CEO SUMMARY: Historically, there was virtually no market for buying and selling pathology practices. That is rapidly changing as the first pathology practice management (PPM) companies enter the marketplace. Their business plan requires them to acquire pathology practices if they are to g…
“February 9, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 2 – February 9, 1998 Issue
Brian Carr and Haywood Cochrane’s Pathology Consultants of America (PCA) is wasting no time. On January 19 the Nashville-based company announced the formal launch of operations. (See TDR, January 19, 1998.) This was followed by another announcement 15 days later that PCA h…
New Pathology PPM Hits Competitive Marketplace
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: Nashville hatched another pathology-based physician practice management firm. This newest competitor was capitalized by pathologists. Its arrival in the competitive marketplace signals further changes to the traditional practice of pathology. Increasingly, it will be business…
“January 19, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
Interesting events continue unfolding at Columbia/HCA Healthcare Corp. Last November the hospital giant announced plans to spin off 108 of its 340 hospitals. Later that month the Columbia signs were removed from its corporate headquarters building in Nashville. Columbia hospitals in …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized